(NP (NP (NN Glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NP (JJ mononuclear) (NNS cells)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN sepsis))))))) (. .))
(S (NP-SBJ-69 (NP (NP (NN Glucocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN GR)) (-RRB- -RRB-))) (NN hormone-binding) (NN activity)) (VP (VBD was) (VP (VBN studied) (NP (-NONE- *-69)) (PP (IN by) (NP (DT a) (JJ whole-cell) (NN method))) (PP (IN in) (NP (NP (NP (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN MNC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (JJ peripheral) (NN blood)) (PP (IN of) (NP (CD 7) (NNS patients))))))) (PP-TMP (IN during) (NP (NP (DT the) (JJ hemodynamic) (JJ compensatory) (NN phase)) (PP (IN of) (NP (NN sepsis))))))) (. .))
(S (NP-SBJ (CD 4) (NNS patients)) (VP (VBD were) (VP (VBG receiving) (NP (NP (NN dopamine)) (, ,) (SBAR (WHNP-70 (WDT which)) (S (NP-SBJ (-NONE- *T*-70)) (VP (VBD did) (RB not) (VP (VB affect) (NP (DT the) (NN GR) (NN count))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS patients) (POS ')) (NN plasma) (NN cortisol) (NNS concentrations)) (VP (VBD were) (ADJP-PRD-COOD (ADJP (JJ normal)) (CC or) (ADJP (RB slightly) (JJ elevated)))) (. .))
(S (PP (IN Despite) (NP (DT a) (JJ wide) (NN range))) (, ,) (NP-SBJ (NP (DT the) (NN mean) (NN GR) (NP-COOD (NP (NN count)) (CC and) (NP (NN affinity)))) (PP (IN in) (NP (NP (NN MNC)) (PP (IN from) (NP (JJ septic) (NNS patients)))))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN from) (NP (NP (DT those)) (PP (IN in) (NP (JJ normal) (NNS controls))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NNS glucocorticoids)) (VP (MD could) (VP (ADVP (RB still)) (VP (VB be) (ADJP-PRD (JJ effective)) (PP (IN in) (NP (NP (DT the) (JJ hemodynamic) (JJ compensatory) (NN phase)) (PP (IN of) (NP (NN sepsis)))))))))))))) (. .))
